THE MOLECULAR-BASIS OF CANNABINOID ACTIVITY

被引:97
作者
MAKRIYANNIS, A
RAPAKA, RS
机构
[1] NATL INST DRUG ABUSE,ROCKVILLE,MD 20857
[2] UNIV CONNECTICUT,INST MAT SCI,STORRS,CT 06269
关键词
D O I
10.1016/0024-3205(90)90147-J
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cannabinoids have been known to exhibit a wide variety of biological effects. Over the past fifty years numerous analogs were synthesized in an attempt to understand the structural requirements for each cannabinoid activity. Only recently, however, some important findings have focused new attention on this field of research. These findings include: (a) The development of novel "non-classical" potent cannabinoid analogs which exhibit similar pharmacological profiles with their "classical" counter[arts; (b) The demonstration that there are specific cannabinoid binding sites in cell cultures as well as in mammalian brains; (c) Biophysical studies related to the interactions of cannabinoids with membranes which lead to a better understanding of those molecular properties which are required for cannabinoid activity; (d) Detailed and uniform pharmacological testing on a sizeable number of analogs allowing for a more detailed dissection of the cannabinoid effects and respective "structure activity relationships." The newly increased interest in cannabinoid research opens the door for a better understanding and potential treatment in cases of abuse as well as novel therapeutic opportunities through the design and synthesis of pharmacologically more selective analogs. © 1990.
引用
收藏
页码:2173 / 2184
页数:12
相关论文
共 76 条
[21]  
HILLARD CJ, 1985, J PHARMACOL EXP THER, V232, P579
[22]   EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL ON GLUCAGON RECEPTOR COUPLING TO ADENYLATE-CYCLASE IN RAT-LIVER PLASMA-MEMBRANES [J].
HILLARD, CJ ;
BLOOM, AS ;
HOUSLAY, MD .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (16) :2797-2803
[23]   STRUCTURE-ACTIVITY-RELATIONSHIPS IN MAN OF CANNABIS CONSTITUENTS, AND HOMOLOGS AND METABOLITES OF DELTA-9-TETRAHYDROCANNABINOL [J].
HOLLISTER, LE .
PHARMACOLOGY, 1974, 11 (01) :3-11
[24]  
HOWLETT AC, 1984, MOL PHARMACOL, V26, P532
[25]  
HOWLETT AC, 1985, MOL PHARMACOL, V27, P429
[26]  
HUNTER SA, 1988, MARIJUANA INT RES RE, P399
[27]  
JARBE TUC, 1980, PSYCHOPHARMACOLOGY, V71, P281, DOI 10.1007/BF00433063
[28]   CANNABIMIMETIC ACTIVITY (DELTA-1-THC CUE) OF CANNABIDIOL MONOMETHYL ETHER AND 2 STEREOISOMERIC HEXAHYDROCANNABINOLS IN RATS AND PIGEONS [J].
JARBE, TUC ;
HILTUNEN, AJ ;
LANDER, N ;
MECHOULAM, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 25 (02) :393-399
[29]   EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL ON NEUROTRANSMITTER ACCUMULATION AND RELEASE MECHANISMS IN RAT FOREBRAIN SYNAPTOSOMES [J].
JOHNSON, KM ;
HO, BT ;
DEWEY, WL .
LIFE SCIENCES, 1976, 19 (03) :347-356
[30]   SELECTIVE AND POTENT ANALGETICS DERIVED FROM CANNABINOIDS [J].
JOHNSON, MR ;
MELVIN, LS ;
ALTHUIS, TH ;
BINDRA, JS ;
HARBERT, CA ;
MILNE, GM ;
WEISSMAN, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S271-S282